Home Sectors Industrials Current Valuation: EnPro Industries Inc (NYSE: NPO)

Current Valuation: EnPro Industries Inc (NYSE: NPO)


EnPro Industries Inc is part of the industrials sector and industrial products industry. The company CEO is Stephen E. Macadam. EnPro Industries Inc is engaged in the designing, developing, manufacturing, and marketing engineered industrial products. It operates with three segments namely Sealing Products, Engineered Products and Power Systems.

Previous Intraday Trading Performance:

The NPO stock showed a previous change of -4.75% with an open at 73.47 and a close of 70.23. It reached an intraday high of 73.47 and a low of 69.97.

SeekingAlpha:  EnPro Industries prices offering of $350M 5.75% senior notes due 2026


The stock has a market cap of $1.5b with 21.0m shares outstanding, of which the float is 20.0m shares. Trading volume reached 119,400 shares compared to its average volume of 117,795 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, EnPro Industries Inc shares returned -5.36% and in the past 30 trading days it returned -6.48%. Over three months, it changed -3.51%. In one year it has changed -13.15% and within that year its 52-week high was 94.79 and its 52-week low was 63.73. NPO stock is 10.20% above its 52 Week Low.

Our calculations show a 200 day moving average of 76.84 and a 50 day moving average of 74.10. Currently NPO stock is trading -8.60% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

SeekingAlpha:  EnPro Industries prices offering of $350M 5.75% senior notes due 2026


The last annual fiscal EPS for the company was reported at 24.64 that ended on 31st of December 2017, which according to the previous close, that is a PE of 2.85. Based on 3 analyst estimates, the consensus EPS for the next quarter is 1.10. The TTM EPS is 3.00, which comes to a TTM PE of 23.41.

The following are the last four quarter reported earnings per share:
06-30-2018:  0.75
03-31-2018:  0.85
12-31-2017:  0.67
09-30-2017:  0.73

The dividend per share is currently 0.96, which is a dividend yield of 1.36%. Also, the payout ratio is 32.00%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 65.03, which means it may be overvalued by -7.99%

Indicators to Watch:

Short-interest is 785,115, which is 3.75% of shares outstanding. The short-interest ratio or days-to-cover ratio is 6.74. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 1.09

Business Wire:  Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 87.74%, return on assets is 32.60%, profit margin is 4.09%, price-to-sales is 1.37 and price-to-book is 1.79.

Company Scores:

All scores are out of six:
 3  :Valuation Score
 6  :Past Performance Score
 5  :Financial Strength Score
 0  :Future Growth Score
 2  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.